🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationState pharmacy board compounding enforcement actions — looking for input Page 5

State pharmacy board compounding enforcement actions — looking for input

TomTeleRx Thu, Oct 9, 2025 at 8:18 AM 34 replies 1,751 viewsPage 5 of 7
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Oct 9, 2025 at 3:23 PM#21

PeptideChemSF — that is really helpful context on State pharmacy board. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

Last edited: Oct 9, 2025 at 7:23 PM
19 15ingrid_STO, pete_nash, hank_denver and 16 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Oct 9, 2025 at 3:40 PM#22

To answer Dr.EndoEP's question specifically:

From a clinical standpoint, State pharmacy board is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

40 18LeilaHI, marcus_mpls, DeniseRN_TPA and 37 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Oct 9, 2025 at 3:57 PM#23

Thank you hank_denver! This is incredibly helpful. Taking this to my next appointment. 🙏

18 9Dr.NutriCornell, pam_stl, wei_SG and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Oct 9, 2025 at 4:14 PM#24

Relevant to State pharmacy board — here is my latest bloodwork comparison:

Key improvements: A1C 7.2% → 5.3%, triglycerides 207 → 107 mg/dL, hsCRP 6.0 → 1.3 mg/L. All on tirzepatide for 11 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

44 21sophie_paris, mel_PDX, Dr.AddMedPHL and 41 others
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Oct 9, 2025 at 4:31 PM#25

Slightly tangential to State pharmacy board but hank_denver reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

33 18AttorneyGrant, DebRD_ATL, KristenIndy and 30 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register